# Extramural Research Programs in the Neurosciences and Neurological Disorders (93.853)

Source: https://welltoldgrants.com/programs/93-853-extramural-research-programs-in-the-neurosciences-and/  
Publisher: Well Told Grants. Data: USAspending.gov and Grants.gov, updated November 7, 2026.

Extramural Research Programs in the Neurosciences and Neurological Disorders is run by Department of Health and Human Services. From fiscal 2021 to 2025 it awarded $9.1 billion in 8,641 grants, about $1.0 million per award.

## Objectives

(1) To support extramural research funded by the National Institute of Neurological Disorders and Stroke (NINDS) including: basic research that explores the fundamental structure and function of the brain and the nervous system; research to understand the causes and origins of pathological conditions of the nervous system with the goal of preventing these disorders; research on the natural course of neurological disorders; improved methods of disease prevention; new methods of diagnosis and treatment; drug development; development of neural devices; clinical trials; and research training in basic, translational and clinical neuroscience. The Institute is the largest funder of basic neuroscience in the US and supports research on topics including but not limited to: development of the nervous system, including neurogenesis and progenitor cell biology, signal transduction in development and plasticity, and programmed cell death; synapse formation, function, and plasticity; learning and memory; channels, transporters, and pumps; circuit formation and modulation; behavioral and cognitive neuroscience; sensorimotor learning, integration and executive function; neuroendocrine systems; sleep and circadian rhythms; and sensory and motor systems. In addition, the Institute supports basic, translational and clinical studies on a number of disorders of the nervous system including (but not limited to): stroke; traumatic injury to the brain, spinal cord and peripheral nervous system; neurodegenerative disorders; movement disorders; brain tumors; convulsive disorders; infectious disorders of the brain and nervous system; immune disorders of the brain and nervous system, including multiple sclerosis; disorders related to sleep; and pain. Programmatic areas, which are primarily supported by the Division of Neuroscience, are also supported by the Division of Extramural Activities, the Division of Translational Research, the Division of Clinical Research, the Office of Training and Workforce Development, the Office of Programs to Enhance the Neuroscience Workforce, and the Office of International Activities. (2) To expand and improve the Small Business Innovation Research (SBIR) program; to increase private sector commercialization of innovations derived from Federal research and development; to increase small business participation in Federal research and development; and to foster and encourage participation of socially and economically disadvantaged small business concerns and women-owned small business concerns in technological innovation. To utilize the Small Business Technology Transfer (STTR) program; to stimulate and foster scientific and technological innovation through cooperative research and development carried out between small business concerns and research institutions; to foster technology transfer between small business concerns and research institutions; to increase private sector commercialization of innovations derived from Federal research and development; and to foster and encourage participation of socially and economically disadvantaged small business concerns and women-owned small business concerns in technological innovation.

## Funding by fiscal year

| Year | Amount | Awards |
|---|---|---|
| 2021 | $1.8 billion | 4,074 |
| 2022 | $1.8 billion | 4,363 |
| 2023 | $1.8 billion | 4,253 |
| 2024 | $1.8 billion | 4,179 |
| 2025 | $1.8 billion | 3,920 |

## Largest recipients

| Recipient | State | Amount |
|---|---|---|
| The General Hospital Corporation | Massachusetts | $288 million |
| The Regents of the University of California, San Francisco | California | $277 million |
| The Johns Hopkins University | Maryland | $276 million |
| The Trustees of Columbia University in the City of New York | New York | $226 million |
| Regents of the University of Michigan | Michigan | $221 million |
| The Washington University | Missouri | $207 million |
| Yale Univ | Connecticut | $192 million |
| The Leland Stanford Junior University | California | $192 million |
| The Trustees of the University of Pennsylvania | Pennsylvania | $192 million |
| Northwestern University | Illinois | $183 million |
| University of California, San Diego | California | $181 million |
| University of Pittsburgh - of the Commonwealth System of Higher Education | Pennsylvania | $169 million |
| University of California, Los Angeles | California | $168 million |
| Emory University | Georgia | $143 million |
| University of Florida | Florida | $136 million |
| Regents of the University of Minnesota | Minnesota | $127 million |
| Duke University | North Carolina | $122 million |
| Baylor College of Medicine | Texas | $104 million |
| New York University | New York | $103 million |
| The University of Iowa | Iowa | $98.6 million |

## Open opportunities

- [Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)](https://welltoldgrants.com/grants/rfa-ns-26-001-amyotrophic-lateral-sclerosis-als-intermediate-patient/), closes November 10, 2026
- [Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-369-ethical-legal-and-social-implications-elsi-exploratory/), closes November 18, 2026
- [Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-371-ethical-legal-and-social-implications-elsi-research-r01/), closes November 18, 2026
- [NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-052-nih-strokenet-clinical-trials-and-biomarker-studies-for/), closes November 19, 2026
- [HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)](https://welltoldgrants.com/grants/rfa-at-25-003-heal-initiative-pain-research-enhancement-program-prep-r15/), closes November 23, 2026
- [Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)](https://welltoldgrants.com/grants/rfa-od-27-008-maximizing-the-scientific-value-of-data-generated-by/), closes December 2, 2026
- [Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-24-296-emerging-global-leader-award-k43-independent-clinical-trial/), closes December 3, 2026
- [Emerging Global Leader Award (K43 Independent Clinical Trial Required)](https://welltoldgrants.com/grants/par-24-295-emerging-global-leader-award-k43-independent-clinical-trial/), closes December 3, 2026
- [NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)](https://welltoldgrants.com/grants/rfa-od-24-011-nih-research-software-engineer-rse-award-r50-clinical/), closes December 4, 2026
- [Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)](https://welltoldgrants.com/grants/par-24-214-academic-research-enhancement-award-area-for-undergraduate/), closes January 7, 2027
- [HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-ns-25-023-heal-initiative-studies-to-enable-analgesic-discovery-r61/), closes January 15, 2027
- [HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)](https://welltoldgrants.com/grants/rfa-da-28-011-heal-initiative-integrative-management-of-chronic-pain-and/), closes January 26, 2027
- [HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-da-28-012-heal-initiative-integrative-management-of-chronic-pain-and/), closes January 26, 2027
- [Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-24-268-biomedical-research-environment-and-sponsored-programs/), closes January 27, 2027
- [BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-ns-24-031-brain-initiative-preclinical-proof-of-concept-for-novel/), closes January 28, 2027
- [Translational Neural Devices (R61/R33 - Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-053-translational-neural-devices-r61-r33-clinical-trial-optional/), closes January 28, 2027
- [BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-mh-26-170-brain-initiative-development-and-validation-of-novel-tools/), closes February 8, 2027
- [BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-dc-27-004-brain-initiative-exploratory-research-opportunities-using/), closes February 11, 2027
- [NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-lm-28-001-nlm-institutional-grants-for-research-training-in-biomedical/), closes February 11, 2027
- [NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-27-100-nih-cdc-and-fda-small-business-innovation-research/), closes April 5, 2027
- [NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-27-102-nih-small-business-technology-transfer-grant-parent-sttr/), closes April 5, 2027
- [Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-185-mentored-patient-oriented-research-career-development-award/), closes May 7, 2027
- [Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required)](https://welltoldgrants.com/grants/pa-24-175-mentored-research-scientist-development-award-parent-k01/), closes May 7, 2027
- [Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-176-mentored-research-scientist-development-award-parent-k01/), closes May 7, 2027
- [Independent Scientist Award (Parent K02 - Independent Clinical Trial Required)](https://welltoldgrants.com/grants/pa-24-178-independent-scientist-award-parent-k02-independent-clinical/), closes May 7, 2027
- [Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-179-independent-scientist-award-parent-k02-independent-clinical/), closes May 7, 2027
- [NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-194-nih-pathway-to-independence-award-parent-k99-r00/), closes May 7, 2027
- [NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)](https://welltoldgrants.com/grants/pa-24-193-nih-pathway-to-independence-award-parent-k99-r00/), closes May 7, 2027
- [Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)](https://welltoldgrants.com/grants/pa-24-184-mentored-patient-oriented-research-career-development-award/), closes May 8, 2027
- [Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)](https://welltoldgrants.com/grants/pa-24-181-mentored-clinical-scientist-research-career-development/), closes May 8, 2027
- [Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-182-mentored-clinical-scientist-research-career-development/), closes May 8, 2027
- [BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-mh-26-120-brain-initiative-reagent-resources-for-brain-cell-type/), closes June 15, 2027
- [BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)](https://welltoldgrants.com/grants/rfa-mh-26-140-brain-initiative-brain-behavior-quantification-and/), closes June 15, 2027
- [Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-24-254-change-of-recipient-organization-type-7-parent-clinical/), closes July 12, 2027
- [Successor-in-Interest (Type 6 Parent Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-24-253-successor-in-interest-type-6-parent-clinical-trial/), closes July 17, 2027
- [Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-24-293-blueprint-neurotherapeutics-network-bpn-biologic-based-drug/), closes August 18, 2027
- [NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-25-080-nih-support-for-conferences-and-scientific-meetings-parent/), closes September 7, 2027
- [Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)](https://welltoldgrants.com/grants/par-24-330-interventions-to-reduce-sleep-health-disparities-r01/), closes September 7, 2027
- [BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-ns-27-015-brain-initiative-connectivity-across-scales-brain-connects/), closes October 4, 2027
- [Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-327-translational-efforts-to-advance-gene-based-therapies-for/), closes October 8, 2027
- [Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-059-innovation-grants-to-nurture-initial-translational-efforts/), closes October 20, 2027
- [Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-060-innovation-grants-to-nurture-initial-translational-efforts/), closes October 20, 2027
- [Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-225-innovation-grants-to-nurture-initial-translational-efforts/), closes October 20, 2027
- [Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-mh-27-125-mechanistic-evaluation-of-therapeutic-targets-derived-from/), closes October 28, 2027
- [Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)](https://welltoldgrants.com/grants/par-25-149-limited-competition-renewal-of-existing-ninds-supported/), closes November 5, 2027
- [BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-da-27-004-brain-initiative-theories-models-and-methods-for-analysis/), closes November 8, 2027
- [Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-215-career-transition-award-for-ninds-intramural-clinician/), closes November 12, 2027
- [Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)](https://welltoldgrants.com/grants/par-25-216-career-transition-award-for-ninds-intramural-clinician/), closes November 12, 2027
- [Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-122-pilot-projects-investigating-understudied-proteins/), closes November 16, 2027
- [Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-024-development-of-biomarkers-or-composite-biomarkers-for/), closes January 7, 2028
- [Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-144-dissemination-and-implementation-research-in-health-r01/), closes January 7, 2028
- [Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-233-dissemination-and-implementation-research-in-health-r03/), closes January 7, 2028
- [Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-143-dissemination-and-implementation-research-in-health-r21/), closes January 7, 2028
- [Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-134-academic-research-enhancement-award-area-for-undergraduate/), closes January 7, 2028
- [Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-298-research-enhancement-award-program-reap-for-health/), closes January 7, 2028
- [NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-25-302-nih-small-research-grant-program-parent-r03-clinical/), closes January 7, 2028
- [NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-25-301-nih-research-project-grant-parent-r01-clinical-trial/), closes January 7, 2028
- [NIH Research Project Grant (Parent R01 Clinical Trial Required)](https://welltoldgrants.com/grants/pa-25-305-nih-research-project-grant-parent-r01-clinical-trial/), closes January 7, 2028
- [Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-383-blueprint-medtech-translator-ug3-uh3-clinical-trial-optional/), closes January 28, 2028
- [Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)](https://welltoldgrants.com/grants/pa-25-168-ruth-l-kirschstein-national-research-service-award-nrsa/), closes May 4, 2028
- [Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)](https://welltoldgrants.com/grants/pa-25-425-ruth-l-kirschstein-national-research-service-award-nrsa/), closes May 7, 2028
- [Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)](https://welltoldgrants.com/grants/pa-25-422-ruth-l-kirschstein-national-research-service-award-nrsa/), closes May 7, 2028
- [BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-ns-27-002-brain-initiative-integrative-team-research-brain-circuits/), closes June 23, 2028
- [Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-27-076-lasker-clinical-research-scholar-s-program-si2-r00/), closes July 7, 2028
- [Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-414-support-for-research-excellence-sure-award-r16-clinical/), closes September 7, 2028
- [Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-415-support-for-research-excellence-first-independent-research/), closes September 7, 2028
- [Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-ai-27-014-development-of-candidate-medical-countermeasures-mcms-and/), closes October 9, 2028
- [Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-26-001-administrative-supplements-to-existing-nih-grants-and/), closes November 30, 2028
- [Limited Competition: Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-27-067-limited-competition-instrumentation-grant-program-for/), closes January 26, 2029
- [BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-ns-28-010-brain-initiative-research-opportunities-using-invasive/), closes February 8, 2029
- [HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)](https://welltoldgrants.com/grants/rfa-ns-27-007-heal-initiative-non-addictive-analgesic-therapeutics/), closes February 20, 2029
- [NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)](https://welltoldgrants.com/grants/par-27-065-ninds-efficacy-and-exploratory-clinical-trials-ug3-uh3/), closes March 9, 2029
- [SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-27-098-sbir-sttr-commercialization-readiness-pilot-crp-program/), closes April 5, 2029
- [NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-27-101-nih-small-business-innovation-research-sbir-phase-iib/), closes April 5, 2029
- [Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-27-037-predoctoral-to-postdoctoral-transition-award-parent-f99-k00/), closes April 8, 2029
- [NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-27-051-nih-brain-development-cohorts-nbdc-and-population-assessment/), closes April 17, 2029
- [NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-27-036-nih-research-education-program-research-experiences-parent/), closes May 5, 2029
- [NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-27-035-nih-research-educational-program-mentoring-activities/), closes May 5, 2029
- [NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-26-002-nih-collaborative-international-research-project-parent-pf5/), closes May 7, 2029
- [NIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-27-034-nih-research-education-program-courses-curriculum-methods/), closes May 25, 2029
- [Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-27-072-bioengineering-research-grants-brg-r01-clinical-trial/), closes July 5, 2029
- [Institutional Mentored Career Development Award (Parent K12) (Clinical Trials Not Allowed)](https://welltoldgrants.com/grants/pa-27-030-institutional-mentored-career-development-award-parent-k12/), closes July 12, 2029
- [Academic Career Excellence (ACE) Award (K32 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-27-062-academic-career-excellence-ace-award-k32-independent/), closes July 12, 2029
- [Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-27-003-collaborative-program-grant-for-interdisciplinary-teams-rm1/), closes September 26, 2029
- [Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-27-090-palliative-care-research-across-the-lifespan-leveraging-the/), closes November 5, 2029
- [NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-eb-28-004-nexttech-translational-development-of-next-generation/), closes December 1, 2030
- [HEAL Initiative: Program to Reveal and Evaluate Cells-to-gene Information that Specify Intricacies, Origins and the Nature of (PRECISION) Human Pain Network](https://welltoldgrants.com/grants/rfa-ns-26-013-heal-initiative-program-to-reveal-and-evaluate-cells/), closes not stated
- [HEAL Initiative: Optimization of Therapeutic Medical Devices through Team Science Mechanistic Research (RM1)](https://welltoldgrants.com/grants/rfa-ns-26-028-heal-initiative-optimization-of-therapeutic-medical-devices/), closes not stated
- [Functional Target Validation for Alzheimer's Disease-Related Dementias](https://welltoldgrants.com/grants/rfa-ns-26-034-functional-target-validation-for-alzheimer-s-disease-related/), closes not stated
- [Clinical Trials and Ancillary Studies Conducted within NIH-Funded Clinical Trial Research Networks (UG3/UH3 - Clinical Trial Required)](https://welltoldgrants.com/grants/par-27-007-clinical-trials-and-ancillary-studies-conducted-within-nih/), closes not stated
- [BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System](https://welltoldgrants.com/grants/rfa-ns-28-006-brain-initiative-clinical-studies-to-advance-next-generation/), closes not stated
- [Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) Infrastructure – Clinical Coordinating Center (CCC) and Data Coordinating Center (DCC)](https://welltoldgrants.com/grants/rfa-ns-28-001-strategies-to-innovate-emergency-care-clinical-trials/), closes not stated
- [Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) Infrastructure – Clinical Enrollment Hubs](https://welltoldgrants.com/grants/rfa-ns-28-004-strategies-to-innovate-emergency-care-clinical-trials/), closes not stated
- [Undiagnosed Diseases Network (UDN) Clinical Networks of Diagnostic Excellence](https://welltoldgrants.com/grants/par-27-137-undiagnosed-diseases-network-udn-clinical-networks-of/), closes not stated
- [Undiagnosed Diseases Network (UDN) Clinical and Data Coordinating Center](https://welltoldgrants.com/grants/par-27-135-undiagnosed-diseases-network-udn-clinical-and-data/), closes not stated
- [Undiagnosed Diseases Network (UDN) Diagnostic Research Innovation Center](https://welltoldgrants.com/grants/par-27-136-undiagnosed-diseases-network-udn-diagnostic-research/), closes not stated
- [Research to Improve Rigor, Replicability, and Reproducibility in Biomedical and Behavioral Sciences](https://welltoldgrants.com/grants/par-28-061-research-to-improve-rigor-replicability-and-reproducibility/), closes not stated
- [Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)](https://welltoldgrants.com/grants/rfa-ns-28-009-amyotrophic-lateral-sclerosis-als-intermediate-patient/), closes not stated
- [Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development](https://welltoldgrants.com/grants/par-28-043-blueprint-neurotherapeutics-network-bpn-small-molecule-drug/), closes not stated
- [Limited Competition: BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships](https://welltoldgrants.com/grants/rfa-ns-28-005-limited-competition-brain-initiative-promoting-health-for/), closes not stated
- [Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure – Clinical Research Sites (U24 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-ns-28-007-network-for-excellence-in-neuroscience-clinical-trials/), closes not stated
- [Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure – Clinical Coordinating Center (CCC) & Data Coordinating Center (DCC)](https://welltoldgrants.com/grants/rfa-ns-28-002-network-for-excellence-in-neuroscience-clinical-trials/), closes not stated
- [NIH Stroke Clinical Trials Network (StrokeNet) Infrastructure – Regional Coordinating Stroke Centers (RCCs)](https://welltoldgrants.com/grants/rfa-ns-28-008-nih-stroke-clinical-trials-network-strokenet-infrastructure/), closes not stated
- [NIH Stroke Clinical Trials Network (StrokeNet) Infrastructure – National Coordinating Center (NCC) and National Data Management Center (NDMC)](https://welltoldgrants.com/grants/rfa-ns-28-003-nih-stroke-clinical-trials-network-strokenet-infrastructure/), closes not stated